系统性红斑狼疮患者青光眼发病率:韩国全国性队列研究
该回顾性队列研究基于韩国国民健康保险服务2008-2022年数据,纳入9682例系统性红斑狼疮(SLE)患者并按年龄和性别1:1匹配非SLE对照,评估青光眼发病率及相关危险因素。结果显示SLE组青光眼发病率显著高于对照组(11.34% vs 3.74%;p<0.0001),SLE与青光眼独立相关(校正OR 2.00,95%CI 1.69至2.38),长期使用糖皮质激素进一步增加风险(OR 1.75,95%CI 1.51至2.02)。
要点
- SLE患者青光眼发病率为11.34%,显著高于非SLE对照的3.74%(p<0.0001)。
- SLE与青光眼独立相关,校正OR为2.00(95%CI 1.69至2.38)。
- 长期使用糖皮质激素(≥180天)进一步增加青光眼风险,OR为1.75(95%CI 1.51至2.02)。
核心结论
- SLE与青光眼风险增加相关,尤其在年轻个体和女性中。
- 长期糖皮质激素治疗显著促成该风险。
- 这些发现支持对SLE患者进行定期眼科筛查和审慎的糖皮质激素管理。
研究设计与样本
- 回顾性队列研究,分析韩国国民健康保险服务2008-2022年数据。
- 共纳入9682例SLE患者(ICD-10编码M32和罕见难治性疾病编码V136),按年龄和性别1:1匹配非SLE对照。
- 评估青光眼(ICD-10编码H40和H42)和青光眼疑似(H40.0)的发病率,采用多因素logistic回归识别危险因素,包括长期使用糖皮质激素(≥180天)。
主要发现
- SLE组青光眼发病率为11.34%,对照组为3.74%,差异显著(p<0.0001)。
- SLE组青光眼疑似病例为35.56%,对照组为30.25%,差异显著(p<0.0001)。
- SLE与青光眼独立相关,校正OR为2.00(95%CI 1.69至2.38)。
- 长期使用糖皮质激素进一步增加风险,OR为1.75(95%CI 1.51至2.02)。
- 年发病率趋势显示随时间上升,尤其在SLE患者中。
临床怎么用
- 作者认为这些发现支持对SLE患者进行定期眼科筛查和审慎的糖皮质激素管理。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/AIMS: To assess the incidence of glaucoma in patients with systemic lupus erythematosus (SLE) and to identify associated risk factors using a nationwide population-based cohort. METHODS: This retrospective cohort study analysed data from the Korean National Health Insurance Service (2008-2022). A total of 9682 patients with SLE were identified using ICD-10 code M32 and rare intractable disease code V136 and matched 1:1 to non-SLE controls by age and sex. The incidence of glaucoma (ICD-10 codes H40 and H42) and glaucoma suspect (H40.0) was assessed. Multivariate logistic regression was used to identify risk factors for glaucoma, including long-term corticosteroid use (≥180 days). RESULTS: The incidence of glaucoma was significantly higher in the SLE group than in controls (11.34% vs 3.74%; p<0.0001), with a greater prevalence in younger patients (<40 years) and females. Glaucoma suspect cases were also more common in the SLE group (35.56% vs 30.25%; p<0.0001). SLE was independently associated with glaucoma (adjusted OR: 2.00, 95% CI 1.69 to 2.38), and prolonged corticosteroid use further increased the risk (OR: 1.75, 95% CI 1.51 to 2.02). Annual incidence trends showed a rising pattern over time, especially among SLE patients. CONCLUSIONS: SLE is associated with an increased risk of glaucoma, particularly among younger individuals and females. Prolonged corticosteroid therapy significantly contributes to this risk. These findings support the need for regular ophthalmic screening and judicious corticosteroid management in patients with SLE.
引用
- Kim JH, Kim Y, Oraha KM, et al. Incidence of glaucoma in patients with systemic lupus erythematosus: a nationwide cohort study in South Korea. Br J Ophthalmol. 2026. PMID: 41276280. doi:10.1136/bjo-2025-327897
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。